AIM Vaccine Co., Ltd. Class H ( (HK:6660) ) has shared an update.
AIM Vaccine Co., Ltd. has announced the placement of 15,500,000 new H shares under a general mandate, representing approximately 3.15% of existing issued H shares. The shares have been placed with FMF, managed by FML, at a price of HK$5.01 per share, which is a significant discount to recent trading prices. This strategic move is expected to enhance the company’s capital base and potentially strengthen its market position.
More about AIM Vaccine Co., Ltd. Class H
AIM Vaccine Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the biotechnology industry. The company is primarily focused on the development and distribution of vaccines, contributing to public health and safety.
YTD Price Performance: -8.63%
Average Trading Volume: 4,486,167
Technical Sentiment Consensus Rating: Buy
For detailed information about 6660 stock, go to TipRanks’ Stock Analysis page.